Merck has announced Phase I data significantly with a single dose they thought the drug crossed the brain barrier and they had a 58% reduction in A-Beta ...
Operational growth of 6% was due to the addition of Premarin, a legacy Wyeth product and operational improvements in Lyrica and Alliance [ph] revenues. ...